BioCentury
ARTICLE | Company News

Syn X, genOway in CNS and cardiovascular deal

February 21, 2001 8:00 AM UTC

Syn X (CDNX:SYY) and genOway (Lyon, France) will develop drug targets for use in treating cardiovascular and CNS disorders, and will share revenues from products, services, and intellectual property d...